These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2888849)

  • 1. Cyclosporin: measurement of fraction unbound in plasma.
    Legg B; Rowland M
    J Pharm Pharmacol; 1987 Aug; 39(8):599-603. PubMed ID: 2888849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin: erythrocyte binding and an examination of its use to estimate unbound concentration.
    Legg B; Rowland M
    Ther Drug Monit; 1988; 10(1):16-9. PubMed ID: 3376178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saturable binding of cyclosporin A to erythrocytes: estimation of binding parameters in renal transplant patients and implications for bioavailability assessment.
    Legg B; Rowland M
    Pharm Res; 1988 Feb; 5(2):80-5. PubMed ID: 3073383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A model to account for the blood-to-plasma distribution of cyclosporin A in human blood.
    Shibata N; Minouchi T; Ono T; Shimakawa H
    J Pharmacobiodyn; 1990 Jan; 13(1):20-9. PubMed ID: 2341967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model to account for the variation in cyclosporin binding to plasma lipids in transplant patients.
    Legg B; Gupta SK; Rowland M
    Ther Drug Monit; 1988; 10(1):20-7. PubMed ID: 3287705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative determination of cyclosporin A in whole blood and plasma by high performance liquid chromatography.
    Shibata N; Minouchi T; Hayashi Y; Ono T; Shimakawa H
    Res Commun Chem Pathol Pharmacol; 1987 Aug; 57(2):261-71. PubMed ID: 3310157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of temperature and endogenous factors in blood on concentrations of cyclosporin in plasma measured by high-performance liquid chromatography.
    Shibata N; Minouchi T; Hayashi Y; Shibata H; Ono T; Shimakawa H
    Chem Pharm Bull (Tokyo); 1989 Jul; 37(7):1877-80. PubMed ID: 2805168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An optimized method for measuring cyclosporin A with 125I-labeled cyclosporin.
    Felder RA; Mifflin TE; Bastani B
    Clin Chem; 1986 Jul; 32(7):1378-82. PubMed ID: 3521944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of cyclosporin A in human serum.
    Smith JM; Hows JM; Gordon-Smith EC
    J Clin Pathol; 1983 Jan; 36(1):41-3. PubMed ID: 6822676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra- and interindividual variability in the free fraction of cyclosporine in plasma in recipients of renal transplants.
    Lindholm A; Henricsson S
    Ther Drug Monit; 1989 Nov; 11(6):623-30. PubMed ID: 2595741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High pressure liquid chromatographic determination of cyclosporin-A in human plasma.
    Leyland-Jones B; Clark A; Kreis W; Dinsmore R; O'Reilly R; Young CW
    Res Commun Chem Pathol Pharmacol; 1982 Sep; 37(3):431-44. PubMed ID: 7178653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin-erythromycin interaction in normal subjects.
    Freeman DJ; Martell R; Carruthers SG; Heinrichs D; Keown PA; Stiller CR
    Br J Clin Pharmacol; 1987 Jun; 23(6):776-8. PubMed ID: 3606938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin-A deposits in renal allografts.
    von Willebrand E; Häyry P
    Lancet; 1983 Jul; 2(8343):189-92. PubMed ID: 6135029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of cyclosporin in organ transplant recipients.
    Akhlaghi F; Trull AK
    Clin Pharmacokinet; 2002; 41(9):615-37. PubMed ID: 12126456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin-erythromycin interaction in renal transplant patients.
    Gupta SK; Bakran A; Johnson RW; Rowland M
    Br J Clin Pharmacol; 1989 Apr; 27(4):475-81. PubMed ID: 2655690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved high-performance liquid chromatographic method for analysis of cyclosporin A using an automated sample processor.
    Lachno DR; Patel N; Rose ML; Yacoub MH
    J Chromatogr; 1990 Jan; 525(1):123-32. PubMed ID: 2338433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The determination of metabolite M17 and its meaning for immunosuppressive cyclosporin therapy.
    Khoschsorur G; Auer T; Lanzer G; Petritsch P; Holzer H; Tscheliessnigg KH
    Angiology; 1998 Apr; 49(4):307-14. PubMed ID: 9555934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin A in the blood.
    Lemaire M; Tillement JP
    J Pharm Pharmacol; 1982 Nov; 34(11):715-8. PubMed ID: 6129301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-to-plasma distribution of cyclosporin A in a renal transplant recipient.
    Shibata N; Minouchi T; Hayashi Y; Shibata H; Ono T; Shimakawa H
    Eur J Clin Pharmacol; 1988; 35(4):443-4. PubMed ID: 3058487
    [No Abstract]   [Full Text] [Related]  

  • 20. Gel chromatographic analysis of cyclosporin and its metabolites in human blood compartments.
    Kodobayashi M; Yamamoto K; Takahara S; Okuyama A; Takashima N; Sawada M; Yanaihara C; Kurokawa N
    J Pharm Pharmacol; 1995 Aug; 47(8):693-7. PubMed ID: 8583375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.